Showing results (1-10 of 72) with videos related to
Sort By:
Pageof 8
Military Medicine|July 22, 1999
Use of a critical pathway to move laparoscopic cholecystectomy to the ambulatory surgery arenaJ M Irizarry, M H Graham, P R CordtsExpert Review of Clinical Immunology|March 10, 2017
Commonality of the IL-4/IL-13 pathway in atopic diseasesNamita A Gandhi, Gianluca Pirozzi, Neil M H GrahamArthritis Research & Therapy|October 8, 2016
Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITYAnita Boyapati, Jérôme Msihid, Stefano Fiore, et al.RMD Open|March 21, 2018
Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET studyCem Gabay, Jérôme Msihid, Moshe Zilberstein, et al.Arthritis Research & Therapy|March 22, 2019
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in JapanYoshiya Tanaka, Kazuteru Wada, Yoshinori Takahashi, et al.Arthritis Research & Therapy|April 18, 2019
Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in JapanYoshiya Tanaka, Kazuteru Wada, Yoshinori Takahashi, et al.Nature Reviews. Drug Discovery|October 17, 2015
Targeting key proximal drivers of type 2 inflammation in diseaseNamita A Gandhi, Brandy L Bennett, Neil M H Graham, et al.Journal of the American Academy of Dermatology|January 19, 2016
Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adultsEric L Simpson, Thomas Bieber, Laurent Eckert, et al.Journal of Dermatological Science|May 22, 2019
Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)Diamant Thaçi, Eric L Simpson, Mette Deleuran, et al.Clinical Pharmacology in Drug Development|February 26, 2020
Base and Covariate Population Pharmacokinetic Analyses of Dupilumab Using Phase 3 DataPavel Kovalenko, John D Davis, Meng Li, et al.Pageof 8